Efficacy and safety of olmesartan medoxomil‐amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single‐arm, multi‐center, real‐world study

MLA

Zhaoqiang Cui, et al. “Efficacy and Safety of Olmesartan Medoxomil‐amlodipine Besylate Tablet in Chinese Patients with Essential Hypertension: A Prospective, Single‐arm, Multi‐center, Real‐world Study.” The Journal of Clinical Hypertension, vol. 26, no. 1, Jan. 2024, pp. 5–16. EBSCOhost, https://doi.org/10.1111/jch.14700.

APA

Zhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, Wei Hu, Genshan Ma, Xiaojun Cai, Yafei Jin, Yi Zhao, Liqun He, Ying Li, Peili Bu, Xiaoping Chen, Ruxing Wang, Lin Chen, Peng Dong, Liuliu Feng, Xuebin Han, Mei Hong, Yinglong Hou, … Junbo Ge. (2024). Efficacy and safety of olmesartan medoxomil‐amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single‐arm, multi‐center, real‐world study. The Journal of Clinical Hypertension, 26(1), 5–16. https://doi.org/10.1111/jch.14700

Chicago

Zhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, Wei Hu, Genshan Ma, Xiaojun Cai, Yafei Jin, et al. 2024. “Efficacy and Safety of Olmesartan Medoxomil‐amlodipine Besylate Tablet in Chinese Patients with Essential Hypertension: A Prospective, Single‐arm, Multi‐center, Real‐world Study.” The Journal of Clinical Hypertension 26 (1): 5–16. doi:10.1111/jch.14700.